FSPHX
Price
$30.27
Change
+$0.15 (+0.50%)
Updated
Nov 19 closing price
Net Assets
6.22B
HGHIX
Price
$42.74
Change
-$0.11 (-0.26%)
Updated
Nov 19 closing price
Net Assets
833.98M
Interact to see
Advertisement

FSPHX vs HGHIX

Header iconFSPHX vs HGHIX Comparison
Open Charts FSPHX vs HGHIXBanner chart's image
Fidelity Select Health Care
Price$30.27
Change+$0.15 (+0.50%)
VolumeN/A
Net Assets6.22B
Hartford Healthcare I
Price$42.74
Change-$0.11 (-0.26%)
VolumeN/A
Net Assets833.98M
FSPHX vs HGHIX Comparison Chart in %
View a ticker or compare two or three
VS
FSPHX vs. HGHIX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a Hold and HGHIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. HGHIX (834M). HGHIX pays higher dividends than FSPHX: HGHIX (0.40) vs FSPHX (0.02). FSPHX was incepted earlier than HGHIX: FSPHX (44 years) vs HGHIX (19 years). HGHIX (1.02) is less costly to investors than FSPHX (0.63). FSPHX (40.00) and HGHIX (40.00) have comparable annual turnover. FSPHX has a lower initial minimum investment than HGHIX: FSPHX (0) vs HGHIX (2000). HGHIX annual gain was more profitable for investors over the last year : 5.07 vs. FSPHX (0.02). HGHIX return over 5 years is better than : -7.98 vs. FSPHX (-8.84).
FSPHXHGHIXFSPHX / HGHIX
Total Expense Ratio0.631.0262%
Annual Report Gross Expense Ratio0.631.0262%
Fund Existence44 years19 years-
Gain YTD10.53212.34985%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.22B834M745%
Annual Yield % from dividends0.020.404%
Returns for 1 year0.025.070%
Returns for 3 years10.4713.0280%
Returns for 5 years-8.84-7.98111%
Returns for 10 years39.344.49877%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVTCX55.320.24
+0.44%
Calamos Growth & Income C
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.66N/A
N/A
Bruce
REMVX11.03N/A
N/A
RBC Emerging Markets Value Equity I
SPMHX8.48N/A
N/A
Invesco SteelPath MLP Alpha R5